BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinugasa Y, Nakamura K, Kamitani H, Hirai M, Yanagihara K, Kato M, Yamamoto K. Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction. ESC Heart Fail 2021;8:2103-10. [PMID: 33734604 DOI: 10.1002/ehf2.13290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Crisci G, Israr MZ, Cittadini A, Bossone E, Suzuki T, Salzano A. Heart failure and trimethylamine N-oxide: time to transform a 'gut feeling' in a fact? ESC Heart Fail 2022. [PMID: 36237140 DOI: 10.1002/ehf2.14205] [Reference Citation Analysis]
2 Lu X, Liu J, Zhou B, Wang S, Liu Z, Mei F, Luo J, Cui Y. Microbial metabolites and heart failure: Friends or enemies? Front Microbiol 2022;13:956516. [DOI: 10.3389/fmicb.2022.956516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li D, Lu Y, Yuan S, Cai X, He Y, Chen J, Wu Q, He D, Fang A, Bo Y, Song P, Bogaert D, Tsilidis K, Larsson SC, Yu H, Zhu H, Theodoratou E, Zhu Y, Li X. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis. Am J Clin Nutr 2022;116:230-43. [PMID: 35348578 DOI: 10.1093/ajcn/nqac074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Anderson KM, Ferranti EP, Alagha EC, Mykityshyn E, French CE, Reilly CM. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure. Heart Fail Rev 2022. [PMID: 35726110 DOI: 10.1007/s10741-022-10254-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li N, Zhou J, Wang Y, Chen R, Li J, Zhao X, Zhou P, Liu C, Song L, Liao Z, Wang X, Yan S, Zhao H, Yan H. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure. ESC Heart Fail 2022. [PMID: 35686339 DOI: 10.1002/ehf2.14009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Israr MZ, Zhan H, Salzano A, Voors AA, Cleland JG, Anker SD, Metra M, van Veldhuisen DJ, Lang CC, Zannad F, Samani NJ, Ng LL, Suzuki T; BIOSTAT-CHF investigators (full author list as appendix). Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium. Am Heart J 2022;248:108-19. [PMID: 35278373 DOI: 10.1016/j.ahj.2022.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Takami A, Kinugasa Y, Kamitani H, Nakamura K, Hirai M, Yanagihara K, Matsubara K, Kato M, Yamamoto K. Simple Score to Predict Treatment Response to Low-Dose Tolvaptan in Patients with Heart Failure. Int Heart J . [DOI: 10.1536/ihj.21-558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zou Y, Song X, Liu N, Sun W, Liu B. Intestinal Flora: A Potential New Regulator of Cardiovascular Disease. Aging and disease 2022;13:753. [DOI: 10.14336/ad.2021.1022] [Reference Citation Analysis]
9 Alam MJ, Puppala V, Uppulapu SK, Das B, Banerjee SK. Human microbiome and cardiovascular diseases. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.012] [Reference Citation Analysis]
10 Kinugasa Y, Nakamura K, Kamitani H, Hirai M, Yanagihara K, Kato M, Yamamoto K. Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction. ESC Heart Fail 2021;8:2103-10. [PMID: 33734604 DOI: 10.1002/ehf2.13290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]